US Stock MarketDetailed Quotes

Cogent Biosciences (COGT)

Watchlist
  • 39.530
  • -0.370-0.93%
Close Jan 22 16:00 ET
6.07BMarket Cap-19.28P/E (TTM)

Cogent Biosciences (COGT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-23.66%-64.29M
-27.73%-54.54M
-26.62%-66.51M
-35.26%-207.79M
-37.46%-60.58M
-36.90%-51.98M
-33.17%-42.7M
-32.93%-52.53M
-29.49%-153.62M
-49.86%-44.07M
Net income from continuing operations
-14.58%-80.93M
-24.73%-73.53M
-23.37%-71.99M
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
Operating gains losses
----
----
----
----
----
----
----
----
--8K
----
Depreciation and amortization
4.56%1.15M
7.13%1.16M
6.75%1.14M
21.27%4.35M
39.55%1.11M
28.30%1.1M
-11.18%1.08M
47.44%1.07M
-38.96%3.59M
-15.26%794K
Other non cash items
--300K
----
----
----
----
----
----
----
-25.00%-1.7M
--0
Change In working capital
-64.46%4.76M
204.15%7.84M
-45.38%-4.72M
1.35%11.6M
-122.88%-1.13M
94.41%13.4M
-41.03%2.58M
31.85%-3.24M
1,423.57%11.44M
-27.06%4.94M
-Change in prepaid assets
8.04%806K
110.64%63K
297.10%2.17M
-592.33%-4.33M
-282.93%-3.39M
141.63%746K
-60.43%-592K
-248.73%-1.1M
57.87%-626K
13.35%1.85M
-Change in payables and accrued expense
-69.48%3.97M
132.39%8.15M
-260.06%-6.52M
33.36%17.31M
-23.48%2.61M
45.18%13M
-27.51%3.51M
57.18%-1.81M
8.69%12.98M
-38.51%3.42M
-Change in other current assets
--374K
--0
--0
101.68%2K
300.00%4K
--0
--0
93.33%-2K
88.31%-119K
-108.70%-2K
-Change in other current liabilities
-9.58%-389K
-11.50%-378K
-12.42%-371K
-74.12%-1.39M
-13.13%-362K
-88.83%-355K
-235.64%-339K
-76.47%-330K
90.84%-796K
25.93%-320K
Cash from discontinued investing activities
Operating cash flow
-23.66%-64.29M
-27.73%-54.54M
-26.62%-66.51M
-35.26%-207.79M
-37.46%-60.58M
-36.90%-51.98M
-33.17%-42.7M
-32.93%-52.53M
-29.49%-153.62M
-49.86%-44.07M
Investing cash flow
Cash flow from continuing investing activities
-357.61%-155.05M
110.53%8.91M
6,545.50%69.38M
139.13%38.28M
487.96%61.67M
166.48%60.19M
-8.97%-84.63M
-98.26%1.04M
21.56%-97.82M
-63.08%10.49M
Net PPE purchase and sale
76.79%-65K
11.49%-131K
-681.43%-547K
79.51%-573K
76.19%-75K
-131.40%-280K
88.23%-148K
93.65%-70K
59.26%-2.8M
83.99%-315K
Net investment purchase and sale
-356.31%-154.98M
110.70%9.04M
6,177.02%69.93M
140.88%38.85M
471.51%61.75M
166.88%60.47M
-10.57%-84.48M
-98.17%1.11M
19.37%-95.03M
-64.43%10.8M
Cash from discontinued investing activities
Investing cash flow
-357.61%-155.05M
110.53%8.91M
6,545.50%69.38M
139.13%38.28M
487.96%61.67M
166.48%60.19M
-8.97%-84.63M
-98.26%1.04M
21.56%-97.82M
-63.08%10.49M
Financing cash flow
Cash flow from continuing financing activities
34,734.46%217.37M
18,548.05%47.23M
-88.33%24.97M
31.13%214.45M
26K
-37.60%624K
-100.16%-256K
48,002.70%214.06M
-0.01%163.54M
0
Net issuance payments of debt
--0
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--215.79M
--0
-88.65%24.25M
31.84%213.34M
--0
--0
-100.23%-365K
--213.7M
-0.08%161.82M
--0
Proceeds from stock option exercised by employees
190.06%1.81M
-95.41%5K
102.25%720K
-35.06%1.12M
--26K
-46.67%624K
6.86%109K
-20.00%356K
6.45%1.72M
--0
Net other financing activities
---235K
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
34,734.46%217.37M
18,548.05%47.23M
-88.33%24.97M
31.13%214.45M
--26K
-37.60%624K
-100.16%-256K
48,002.70%214.06M
-0.01%163.54M
--0
Net cash flow
Beginning cash position
44.64%127.6M
-41.61%126M
84.42%98.17M
-62.29%53.23M
11.79%97.05M
-58.84%88.22M
33.25%215.8M
-62.29%53.23M
-36.12%141.14M
-38.79%86.81M
Current changes in cash
-122.26%-1.97M
101.25%1.6M
-82.88%27.84M
151.11%44.94M
103.34%1.12M
106.92%8.83M
-343.64%-127.58M
681.15%162.57M
-10.17%-87.91M
-4,823.90%-33.58M
End cash Position
29.46%125.63M
44.64%127.6M
-41.61%126M
84.42%98.17M
84.42%98.17M
11.79%97.05M
-58.84%88.22M
33.25%215.8M
-62.29%53.23M
-62.29%53.23M
Free cash flow
-23.13%-64.35M
-27.59%-54.67M
-27.49%-67.06M
-33.21%-208.36M
-36.65%-60.65M
-37.20%-52.26M
-28.59%-42.85M
-29.49%-52.6M
-24.64%-156.42M
-41.47%-44.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -23.66%-64.29M-27.73%-54.54M-26.62%-66.51M-35.26%-207.79M-37.46%-60.58M-36.90%-51.98M-33.17%-42.7M-32.93%-52.53M-29.49%-153.62M-49.86%-44.07M
Net income from continuing operations -14.58%-80.93M-24.73%-73.53M-23.37%-71.99M-32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M
Operating gains losses ----------------------------------8K----
Depreciation and amortization 4.56%1.15M7.13%1.16M6.75%1.14M21.27%4.35M39.55%1.11M28.30%1.1M-11.18%1.08M47.44%1.07M-38.96%3.59M-15.26%794K
Other non cash items --300K-----------------------------25.00%-1.7M--0
Change In working capital -64.46%4.76M204.15%7.84M-45.38%-4.72M1.35%11.6M-122.88%-1.13M94.41%13.4M-41.03%2.58M31.85%-3.24M1,423.57%11.44M-27.06%4.94M
-Change in prepaid assets 8.04%806K110.64%63K297.10%2.17M-592.33%-4.33M-282.93%-3.39M141.63%746K-60.43%-592K-248.73%-1.1M57.87%-626K13.35%1.85M
-Change in payables and accrued expense -69.48%3.97M132.39%8.15M-260.06%-6.52M33.36%17.31M-23.48%2.61M45.18%13M-27.51%3.51M57.18%-1.81M8.69%12.98M-38.51%3.42M
-Change in other current assets --374K--0--0101.68%2K300.00%4K--0--093.33%-2K88.31%-119K-108.70%-2K
-Change in other current liabilities -9.58%-389K-11.50%-378K-12.42%-371K-74.12%-1.39M-13.13%-362K-88.83%-355K-235.64%-339K-76.47%-330K90.84%-796K25.93%-320K
Cash from discontinued investing activities
Operating cash flow -23.66%-64.29M-27.73%-54.54M-26.62%-66.51M-35.26%-207.79M-37.46%-60.58M-36.90%-51.98M-33.17%-42.7M-32.93%-52.53M-29.49%-153.62M-49.86%-44.07M
Investing cash flow
Cash flow from continuing investing activities -357.61%-155.05M110.53%8.91M6,545.50%69.38M139.13%38.28M487.96%61.67M166.48%60.19M-8.97%-84.63M-98.26%1.04M21.56%-97.82M-63.08%10.49M
Net PPE purchase and sale 76.79%-65K11.49%-131K-681.43%-547K79.51%-573K76.19%-75K-131.40%-280K88.23%-148K93.65%-70K59.26%-2.8M83.99%-315K
Net investment purchase and sale -356.31%-154.98M110.70%9.04M6,177.02%69.93M140.88%38.85M471.51%61.75M166.88%60.47M-10.57%-84.48M-98.17%1.11M19.37%-95.03M-64.43%10.8M
Cash from discontinued investing activities
Investing cash flow -357.61%-155.05M110.53%8.91M6,545.50%69.38M139.13%38.28M487.96%61.67M166.48%60.19M-8.97%-84.63M-98.26%1.04M21.56%-97.82M-63.08%10.49M
Financing cash flow
Cash flow from continuing financing activities 34,734.46%217.37M18,548.05%47.23M-88.33%24.97M31.13%214.45M26K-37.60%624K-100.16%-256K48,002.70%214.06M-0.01%163.54M0
Net issuance payments of debt --0------------------0----------------
Net common stock issuance --215.79M--0-88.65%24.25M31.84%213.34M--0--0-100.23%-365K--213.7M-0.08%161.82M--0
Proceeds from stock option exercised by employees 190.06%1.81M-95.41%5K102.25%720K-35.06%1.12M--26K-46.67%624K6.86%109K-20.00%356K6.45%1.72M--0
Net other financing activities ---235K------------------------------------
Cash from discontinued financing activities
Financing cash flow 34,734.46%217.37M18,548.05%47.23M-88.33%24.97M31.13%214.45M--26K-37.60%624K-100.16%-256K48,002.70%214.06M-0.01%163.54M--0
Net cash flow
Beginning cash position 44.64%127.6M-41.61%126M84.42%98.17M-62.29%53.23M11.79%97.05M-58.84%88.22M33.25%215.8M-62.29%53.23M-36.12%141.14M-38.79%86.81M
Current changes in cash -122.26%-1.97M101.25%1.6M-82.88%27.84M151.11%44.94M103.34%1.12M106.92%8.83M-343.64%-127.58M681.15%162.57M-10.17%-87.91M-4,823.90%-33.58M
End cash Position 29.46%125.63M44.64%127.6M-41.61%126M84.42%98.17M84.42%98.17M11.79%97.05M-58.84%88.22M33.25%215.8M-62.29%53.23M-62.29%53.23M
Free cash flow -23.13%-64.35M-27.59%-54.67M-27.49%-67.06M-33.21%-208.36M-36.65%-60.65M-37.20%-52.26M-28.59%-42.85M-29.49%-52.6M-24.64%-156.42M-41.47%-44.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More